ArticleACS omega2025
Experimental and Computational Insights of a Benzytrietylammonium [CoBr
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this paper, we present a combined experimental and computational study of a cobalt-(II) complex with the organic ligand benzyltriethylammonium bromide. The complex was characterized by IR spectroscopy and single-crystal X-ray crystallography. The molecular geometries, electronic transitions, and vibrational frequencies were calculated using density functional theory (DFT) at the B3LYP/LanL2DZ level. Based on the unit cell parameters obtained from experimental data, DFT calculations were performed to correlate with the vibrational spectrum analysis. The theoretical parameters derived from DFT showed strong agreement with the experimental results. A qualitative description of the charge-transfer character was carried out using natural bond orbital (NBO) analysis. The energies of the highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) were calculated, and the band gap was determined. Furthermore, the complex demonstrated significant degradation of methylene blue (MB) under sunlight irradiation. In vitro, the cobalt-(II) complex exhibited strong inhibitory activity against key inflammatory enzymes, particularly myeloperoxidase (MPO), with a half-maximal inhibitory concentration (IC
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.